4671 Stock Overview
A medical service company, provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 6/6 |
Rewards
Risk Analysis
No risks detected for 4671 from our risk checks.
FALCO HOLDINGS Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,290.00 |
| 52 Week High | JP¥2,370.00 |
| 52 Week Low | JP¥1,804.00 |
| Beta | 0.23 |
| 11 Month Change | -0.39% |
| 3 Month Change | -2.59% |
| 1 Year Change | 24.59% |
| 33 Year Change | 35.74% |
| 5 Year Change | 31.23% |
| Change since IPO | 101.15% |
Recent News & Updates
Shareholder Returns
| 4671 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | -0.2% | -1.0% | -0.6% |
| 1Y | 24.6% | -3.0% | 17.8% |
Return vs Industry: 4671 exceeded the JP Healthcare industry which returned -3% over the past year.
Return vs Market: 4671 exceeded the JP Market which returned 17.8% over the past year.
Price Volatility
| 4671 volatility | |
|---|---|
| 4671 Average Weekly Movement | 2.3% |
| Healthcare Industry Average Movement | 3.4% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in JP Market | 7.4% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 4671 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4671's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | 1,159 | Tadashi Yasuda | www.falco-hd.co.jp |
FALCO HOLDINGS Co., Ltd., a medical service company, provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. It offers clinical testing services in the fields of genetic tests, biochemistry, hematology, pathology, immunology, and microbiology; and genetic testing services. The company also provides medical information technology services; and develops in vitro diagnostics for unmet medical needs.
FALCO HOLDINGS Co., Ltd. Fundamentals Summary
| 4671 fundamental statistics | |
|---|---|
| Market cap | JP¥24.44b |
| Earnings (TTM) | JP¥1.67b |
| Revenue (TTM) | JP¥43.01b |
14.7x
P/E Ratio0.6x
P/S RatioIs 4671 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4671 income statement (TTM) | |
|---|---|
| Revenue | JP¥43.01b |
| Cost of Revenue | JP¥30.08b |
| Gross Profit | JP¥12.92b |
| Other Expenses | JP¥11.26b |
| Earnings | JP¥1.67b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 156.10 |
| Gross Margin | 30.05% |
| Net Profit Margin | 3.87% |
| Debt/Equity Ratio | 1.9% |
How did 4671 perform over the long term?
See historical performance and comparison